Sub-mucosal Dexamethasone for Post-operative Pain and Oedema Control in Lower Third Molar Surgery

J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S816-S819. doi: 10.4103/jpbs.jpbs_8_22. Epub 2022 Jul 13.

Abstract

Background: Surgical excision of the problematic mandibular third molars causes substantial tissue damage and an inflammatory response. Discomfort and edema are common postoperative signs and symptoms caused by the latter. To find out whether dexamethasone may help with the edema and pain that come along with the surgical removal of impacted mandibular third molars, researchers have performed clinical studies.

Methods: Twenty individuals with bilaterally affected mandibular third molars who were scheduled for extraction participated in a prospective trial. At two separate sessions, teeth were raised and cut after buccal ostectomy. Since the surgical operation on the left foot, both patients were administered a mixture of 4 mg dexamethasone submucosal injection and antibiotics for 3 days. On the 1st, 3rd, and 7th postoperative days, edema and pain were assessed.

Results: At the 1st, 3rd, and 7th postoperative days, there was a clinically meaningful decrease in the level of edema and discomfort in both arms.

Conclusions: The current report offers empirical proof that administering a 4 mg dexamethasone submucosal injection during surgery greatly reduced post-surgical edema and discomfort.

Keywords: Dexamethasone; discomfort; edema; impacted mandibular third molars; mucosal injection.